Using nationally representative percentiles to interpret PROMIS pediatric measures

Carle, A.C., Bevans, K.B., Tucker, C.A. et al. Using nationally representative percentiles to interpret PROMIS pediatric measures. Quality of Life Research, November, 2020.

Measurement properties of PROMIS domains for children with Type 1 diabetes

Singh, A., Dasgupta, M., Retherford, D., Fiallo‐Scharer, R., Simpson, P.M. and Panepinto, J.A. Pediatric Diabetes, October, 2020.

Characteristics and impacts of itch in children with inflammatory skin disorders

Fang MM, Nowinski CJ, Lai J, Shaunfield S, Silverberg JI, Rangel SM, Cella D, Paller AS. British Journal of Dermatology, September, 2020.

Identifying clinically meaningful severity categories for PROMIS pediatric measures of anxiety, mobility, fatigue, and depressive symptoms in juvenile idiopathic arthritis and childhood-onset systemic lupus erythematosus

Mann, C.M., Schanberg, L.E., Wang, M., et al. Quality of Life Research, September, 2020.

Can PROMIS domains of pain and physical functioning detect changes in health over time for children with sickle cell disease?

Singh, A., Dasgupta, M., Simpson, P.M., Brousseau, D.C., Panepinto, J.A. Pediatric & Blood Cancer, May, 2020.

Establishing the content validity of PROMIS Pediatric pain interference, fatigue, sleep disturbance, and sleep-related impairment measures in children with chronic kidney disease and Crohn’s disease.

Forrest, C.B., Forrest, K.D., Clegg, J.L. et al. Quality of Life Research, February, 2020.

Expanding construct validity of established and new PROMIS Pediatric measures for children and adolescents receiving cancer treatment.

Reeve, B.B., McFatrich, M., Mack J.W., et al. Pediatric Blood & Cancer, January, 2020.

Reliability and validity of PROMIS® pediatric family relationships short form in children 8–17 years of age with chronic disease.

Cox, E.D., Connolly, J.R., Palta, M. et al. Quality of Life Research. August, 2019.

Clinical meaning of PROMIS pain domains for children with sickle cell disease.

Singh A, Panepinto J. Blood Advances, July 2019, 3(15), 2244-2249.

Use of the new pediatric PROMIS measures of pain and physical experiences for children with sickle cell disease.

Singh, A., Dasgupta, M., Simpson, P. M., & Panepinto, J. A. Pediatric Blood & Cancer, January 2019, 66(5), e27633.

Content validity of the PROMIS® pediatric family relationships measure for children with chronic illness.

Flynn, K. E., Kliems, H., Saoji, N., Svenson, J., & Cox, E. D. Health and Quality of Life Outcomes, October 2018, 16(1), 203.

Importance ratings on patient-reported outcome items for survivorship care: comparison between pediatric cancer survivors, parents, and clinicians.

Jones, C.M., Baker, J.N., Keesey, R.M., Eliason, R.J., Lanctot, J.Q., Clegg, J.L., Mandrell, B.N., Ness, K.K., Krull, K.R., Srivastava, D.K., Forrest, C.B., Hudson, M.M., Robinson, L.L., & Huang, I. Quality of Life Research, July 2018, 27(7), 1877-1884.